| 摘要 |
1. Claims for the Contracting States : BE, CH, DE, GB, IT, LI, LU, NL, SE An animal or human therapeutical composition for improvement of biological consequences of prostaglandin biosynthesis and for asthenia reduction, characterized in that it comprises a protein hydrolysate, which was not subjected to a temperature higher than 85 degrees C, and from 20% to 50% by weight, based on hydrolysate, of plant or animal oils comprising undamaged unsaturated fatty acids essential for prostaglandin metabolism and in that it is a homogeneous paste resulting from the throughout mixture of the dry protein hydrolysate powder and the oils at a temperature in the range from about 20 degrees C to about 55 degrees C. 1. Claims for the Contracting State : AT A method for producing an animal or human therapeutical composition for improvement of biological consequences of prostaglandin bio-synthesis and for asthenia reduction characterized in that protein hydrolysate powder, which was not subjected to a temperature higher than 85 degrees C, and from 20% to 50% by weight, based on hydrolysate, of animal or plant oils comprising unsaturated fatty acids essential for undamaged prostaglandin metabolism are throughoutly mixed at a temperature in the range from about 20 degrees C to about 55 degrees C to produce an homogeneous paste. |
